Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    gadolin
Show Display Options
Rank Status Study
1 Active, not recruiting A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: RO5072759;   Drug: bendamustine

Indicates status has not been verified in more than two years